Skip to main content

. 1990 Mar;53(3):185–187. doi: 10.1136/jnnp.53.3.185

Ticlopidine, a new antithrombotic drug: but is it better than aspirin for longterm use?

PMCID: PMC1014125 PMID: 2182779

185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dennis M. S., Bamford J. M., Sandercock P. A., Warlow C. P. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke. 1989 Nov;20(11):1494–1499. doi: 10.1161/01.str.20.11.1494. [DOI] [PubMed] [Google Scholar]
Gent M., Blakely J. A., Easton J. D., Ellis D. J., Hachinski V. C., Harbison J. W., Panak E., Roberts R. S., Sicurella J., Turpie A. G. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989 Jun 3;1(8649):1215–1220. doi: 10.1016/s0140-6736(89)92327-1. [DOI] [PubMed] [Google Scholar]
Hass W. K., Easton J. D., Adams H. P., Jr, Pryse-Phillips W., Molony B. A., Anderson S., Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989 Aug 24;321(8):501–507. doi: 10.1056/NEJM198908243210804. [DOI] [PubMed] [Google Scholar]
XIIth congress of the International Society on Thrombosis and Haemostasis. Tokyo, Japan, 19-25 August 1989. Abstracts. Thromb Haemost. 1989 Aug 19;62(1):1–647. [PubMed] [Google Scholar]

ACTIONS

RESOURCES